Clinical Trials Browser

Phase 2 × Thymus Neoplasms × Sunitinib × Clear all

NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

Phase 2 Completed

56 enrolled 15 charts

Thymoma, Thymus Neoplasms